Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-03-03T22:21:32.000Z thumbnail image
  3. Check
    27 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:42:07.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T06:24:42.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T21:35:35.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.
    Difference
    1.0%
    Check dated 2025-01-12T17:15:51.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:31:03.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.